Restriction mediated by pAV2 affects the transfer of plasmids in Acinetobacter calcoaceticus

Journal of General Microbiology
E Hinchliffe, A Vivian

Abstract

The naturally occurring plasmid pAV2 restricts the entry of the P class plasmid RP4 and the W class plasmids R388 and S-a into Acinetobacter calcoaceticus strain EBF65/65 from Escherichia coli. The W class plasmids only transfer from E. coli into pAV2-strains. Plasmid RP4 is modified in the presence of pAV2 such that it is no longer restricted on entry into pAV2 recipients of strain EBF65/65.

Citations

Jan 15, 2014·Acta Crystallographica. Section F, Structural Biology Communications·Chikako IwasaAtsushi Nishikawa
Nov 30, 2011·Future Microbiology·Veronica Casas, Stanley Maloy
Jan 30, 2014·International Journal of Biological Macromolecules·Tomonori SuzukiYoshimasa Sagane
Sep 1, 1981·The Journal of Hospital Infection·A VivianC A Fewson
Oct 10, 2006·FEMS Microbiology Reviews·Raúl Fernández-LópezFernando de la Cruz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.